President Donald Trump is actually likely to outline his administration’s long-awaited plan to lower prescription drug prices in a speech Friday. The White House is actually planning to also publish a blueprint of its proposals.
Senior administration officials on Thursday told reporters in which the plan, dubbed “American Patients First,” will increase competition inside the drug market along with create incentives for manufacturers to lower list prices while tweaking components of Medicare to try to lower costs for patients.
Trump has repeatedly chastised drugmakers for their prices, saying they are “getting away with murder.”
Administration officials, including Health along with Human Services Secretary Alex Azar, Food along with Drug Administration Commissioner Scott Gottlieb along with Centers for Medicare along with Medicaid Services Administrator Seema Verma have all teased Trump’s priorities in recent weeks.